Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study.

ABSTRACT:

SUBMITTER: Diaz LA 

PROVIDER: S-EPMC9533375 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature